Our group is investigating the antimicrobial resistance (AMR) mechanisms of novel superbugs (ESKAPE pathogens) and newly emerging Pan-African multidrug-resistant (MDR) pathogens prevalent and diversely distributed in hospital environments, especially those that are implicated in nosocomial infections in the Intensive Care Unit. We are advancing research efforts in hetero-resistance mechanisms, bacterial virulence and pathogenesis, lipopolysaccharide modifications, biofilm-motility interplay in bacterial resistance, toxin-antitoxin, and secretory systems. As we leverage phenotypic algorithms and molecular tools for developing diverse assays to potentiate antibiotic effectiveness and understand opportunistic pathogen antibiotic-evasion pathways, we are also taking advantage of nanoparticles for antibiotic delivery and phage technology to intercept AMR pathways to inform treatment strategies.
Our previous study showed that calcium ions potentiated carbapenems against MDR Enterobacter cloacae (EC) with a 50% reduction in the levels of resistance1. However, the mechanisms by which this is achieved are unclear. We posit that Ca2+ outcompetes EC lipopolysaccharides and deactivates efflux porters to reduce carbapenem resistance. This project will contribute to the fight against AMR and provide relevant therapeutic insights to inform treatment strategies.
Isawumi A, Abban MK, Ayerakwa EA, Mosi L. Calcium Potentiated Carbapenem Effectiveness Against Resistant Enterobacter Species. Microbiology Insights. 2022;15. doi:10.1177/11786361221133728
Isawumi A, Ayerakwa EA, Abban MK, Mosi L. Expression profiles of sporulation genes in multidrug-resistant Bacillus species isolated from intensive care units of Ghanaian hospital. Experimental Biology and Medicine. 2023;248(6):501-507. doi:10.1177/15353702231160336
Molly Kukua Abban, Eunice Ampadubea Ayerakwa, Lydia Mosi, Abiola Isawumi. The burden of hospital acquired infections and antimicrobial resistance, Heliyon, 2023, e20561, ISSN 2405-8440, https://doi.org/10.1016/j.heliyon.2023.e20561
Abban RL, Kwabena S, Duodu S, Mosi L, Abiola Isawumi (2023) Targeting Proteus mirabilis BAM Complex Proteins for Development of Novel Antibiotics. Research Ideas and Outcomes 9: e106849. https://doi.org/10.3897/rio.9.e106849
A. Isawumi, A. Kukua Abban, A. Duodu, A. Mosi, M. Valvano (2020). Klebsiella oxytoca: Evolving superbug from Ghanaian Hospitals. International Journal of Infectious Diseases, 101(1):43-44. https://doi.org/10.1016/j.ijid.2020.09.147.
Microbiology, Sample processing, Bacterial culturing and characterization, cell culturing, drug-assays development, secretory and tracking assays, cell culturing, virulence and infection assays, microscopy, nanoparticle synthesis set up, molecular biology assays, gene expression analysis, LPS profiling, phage isolation, collaborative research, documentation and reporting, mentoring, data curation and analysis
Structural biology tools provide unique avenues for providing structural and functional information on macromolecules that are essential to the pathogenesis of diseases. My lab uses biophysical techniques such as X-ray crystallography and cryo-EM in studying macromolecular structures implicated in diseases and their complexes as well as with natural substrates and inhibitors to understand how these pathogens cause diseases. Our model organisms include HIV, SARS-CoV-2, Buruli Ulcer, and Malaria.
Structural biology tools have been used extensively in understanding atomic level interactions of macromolecular entities thereby helping elucidate mechanisms that underlie diseases, drug discovery where structure guided drug design principles such as fragment-based drug discovery technologies have yielded therapies for diseases that had hitherto been refractory to conventional drug discovery methods. By using a combination of these tools, especially, X-ray crystallography, single particle cryo-electron microscopy (cryo-EM) and small angle X-ray scattering, we seek to provide 3D structural information for macromolecules and their complexes implicated in malaria and Buruli ulcer etiology to aid understanding of pathogenesis of diseases, elucidate the mechanism(s) of drug/inhibitor action, and to aid the discovery of new drugs against these diseases.
Yadav R, Courouble V.V, Dey S.K, Harrison J.J.E.K, Timm J, Hopkins J.B, Slack R.L, Sarafianos S.G, Ruiz F.X, Griffin P, Arnold E. Biochemical and structural insights into SARS-CoV-2 polyprotein processing by Mpro. Sci. Adv.8, eadd2191(2022). DOI:10.1126/sciadv.add2191.
Harrison, J.J.E.K., Passos D.O, Bruhn J.F, Bauman J.D, Tuberty L, DeStefano J.J, Ruiz F.X, Lyumkis D, Eddy Arnold (2021). Cryo-EM structure of the HIV-1 Pol polyprotein provides insights into virion maturation. Sci. Adv.8, eabn9874(2022). DOI:10.1126/sciadv.abn9874.
Courouble, V. V.; Dey, S. K.; Yadav, R.; Timm, J.; Harrison, J.J.E.K.; Ruiz, F. X.; Arnold, E.; Griffin, P. R. Revealing the Structural Plasticity of SARS-CoV-2 nsp7 and nsp8 Using Structural Proteomics. J. Am. Soc. Mass Spectrom. 2021, 32, 1618– 1630, DOI: 10.1021/jasms.1c00086.
Harrison, J.J.E.K.; Tuske, S.; Das, K.; Ruiz, F.X.; Bauman, J.D.; Boyer, P.L.; DeStefano, J.J.; Hughes, S.H.; Arnold, E. Crystal Structure of a Retroviral Polyprotein: Prototype Foamy Virus Protease
-Reverse Transcriptase (PR-RT). Viruses 2021, 13, 1495. https://doi.org/10.3390/v13081495.
Cloning, protein expression and purification, X-ray crystallography, single particle cryo-EM
We work at the intersection of virology, protein biochemistry, immunology and epidemiology with the aim to understand and therapeutically target key replicative and host:virus interaction processes in viruses of pandemic concern.
The project on host-viral interactions and antiviral therapeutics.
Dr. Quashie’s group is studying the impact of endemic comorbidity on West African HIV responses. They lead the WACCBIP long-term HIV Infection CoHort Study, which involves recruiting, sampling, and characterizing HIV infection in 1000 newly diagnosed Ghanaians. Their research has also focused on the West African immune system’s response to SARS-Cov-2 infection and vaccination, and the role of endemic malaria.
Serwaa A, Oyawoye F, Owusu IA, Dosoo D, Manu AA, Sobo AK, Fosu K, Olwal CO, Quashie PK*, Aikins AR*. In vitro analysis suggests that SARS-CoV-2 infection differentially modulates cancer-like phenotypes and cytokine expression in colorectal and prostate cancer cells. Sci Rep. 2024 Oct 19;14(1):24625. doi: 10.1038/s41598-024-75718-1. PMID: 39427065; PMCID: PMC11490510.
Tapela K, Prah DA, Tetteh B, Nuokpem F, Dosoo D, Coker A, Kumi-Ansah F, Amoako E, Assah KO, Kilba C, Nyakoe N, Quansah D, Languon S, Anyigba CA, Ansah F, Agyeman S, Owusu IA, Schneider K, Ampofo WK, Mutungi JK, Amegatcher G, Aniweh Y, Awandare GA, Quashie PK*, Bediako Y*. Cellular immune response to SARS-CoV-2 and clinical presentation in individuals exposed to endemic malaria. Cell Rep. 2024 Aug 27;43(8):114533. doi: 10.1016/j.celrep.2024.114533. Epub 2024 Jul 24. PMID: 39052480; PMCID: PMC11372439
Manu AA, Owusu IA, Oyawoye FO, Languon S, Barikisu IA, Tawiah-Eshun S, Quaye O, Donkor KJ, Paemka L, Amegatcher GA, Denyoh PMD, Oduro-Mensah D, Awandare GA, Quashie PK. Development and utility of a SARS-CoV-2 pseudovirus assay for compound screening and antibody neutralization assays. Heliyon. 2024 May 19;10(10):e31392. doi: 10.1016/j.heliyon.2024.e31392. PMID: 38826759; PMCID: PMC11141373.
Olwal CO, Fabius JM, Zuliani-Alvarez L, Eckhardt M, Kyei GB, Quashie PK, Krogan NJ, Bouhaddou M, Bediako Y. Network modeling suggests HIV infection phenocopies PI3K-AKT pathway mutations to enhance HPV-associated cervical cancer. Molecular Omics. 2023 Aug 14;19(7):538-551. doi: 10.1039/d3mo00025g. PMID: 37204043.
Tapela K, Opurum PC, Nuokpem FY, Tetteh B, Siaw GK, Humbert MV, Tawiah-Eshun S, Barakisu AI, Asiedu K, Arhin SK, Manu AA, Appiedu-Addo SNA, Obbeng L, Quansah D, Languon S, Anyigba C, Dosoo D, Edu NKO, Oduro-Mensah D, Ampofo W, Tagoe E, Quaye O, Donkor IO, Akorli J, Aniweh Y, Christodoulides M, Mutungi J, Bediako Y, Rayner JC, Awandare GA, McCormick CJ, Quashie PK. Development of an Affordable ELISA Targeting the SARS-CoV-2 Nucleocapsid and Its Application to Samples from the Ongoing COVID-19 Epidemic in Ghana. Mol Diagn Ther. 2023 Sep;27(5):583-592. doi: 10.1007/s40291-023-00655-0. Epub 2023 Jul 18. PMID: 37462793; PMCID: PMC10435612.
Mammalian Cell Culture, qRTPCR, Flow Cytometry, Sequencing, assay development
The Mensah-Brown lab at WACCBIP, University of Ghana works on malaria parasite biology and immunology, focused on parasite invasion strategies as well as the identification and validation of potential targets for drug and vaccine development. This is particularly important since malaria remains a major global health challenge. The recent resurgence in malaria morbidity and mortality signals the need to identify and develop drugs and vaccines that can aid the elimination of malaria.
PFD1140w is a gene which has been shown to upregulated with var2CSA in placental malaria parasites. In our recent studies, we found that PFD1140w transcripts were similarly upregulated with var2CSA in parasites from children with severe malaria compared to parasites from children with uncomplicated malaria. Our unpublished data further showed that anti-PFD1140w antibody levels in children with severe were significantly elevated when compared to children with uncomplicated malaria, while anti-PFD1140w antibodies used in combination with anti-var2CSA antibodies showed the ability to disrupt parasite binding to CSA in a limited number of laboratory parasites.
In this project, we will expand our studies to clinical isolates and more laboratory lines to confirm the binding inhibitory activity of these parasites
Francis SE, Malkov VA, Oleinikov AV, Rossnagle E, Wendler JP, Mutabingwa TK, Fried M, Duffy PE. Six genes are preferentially transcribed by the circulating and sequestered forms of Plasmodium falciparum parasites that infect pregnant women. Infect Immun. 2007 Oct;75(10):4838-50. doi: 10.1128/IAI.00635-07. Epub 2007 Aug 13. PMID: 17698567; PMCID: PMC2044550.
Kumar V, Kaur J, Singh AP, Singh V, Bisht A, Panda JJ, Mishra PC, Hora R. PHISTc protein family members localize to different subcellular organelles and bind Plasmodium falciparum major virulence factor PfEMP-1. FEBS J. 2018 Jan;285(2):294-312. doi: 10.1111/febs.14340. Epub 2017 Dec 10. PMID: 29155505.
Fried M, Duffy PE. Analysis of CSA-binding parasites and antiadhesion antibodies. Methods Mol Med. 2002;72:555-60. doi: 10.1385/1-59259-271-6:555. PMID: 12125153.
Sample processing, parasite culture, ELISA, Drug assays, Flow cytometry
Our research group is particularly interested in pathogen evolution, antimicrobial resistance and disease diagnostics. Different techniques in molecular biology, microbiology, and comparative genomics are employed to achieve these goals. Some ongoing work examines pathoadaptive mutations and metabolic regulation of bacterial virulence under varied environmental stress conditions based on a long-term experimental evolution model. We also conduct genomic and metabolic pathway analyses to decipher the mechanisms of antimicrobial resistance. We also aim to improve infectious disease diagnosis using host response transcriptomics and conduct studies in host-pathogen interactions. Salmonella, Vibrio cholerae and Klebsiella pneumoniae are some enteric bacterial pathogens currently studied in our lab. These bacteria occasionally cause invasive bloodstream infections or sepsis, with fatal outcomes. Under iron stress, iron sequestration and uptake systems such as siderophores are engaged to scavenge for iron to make them more invasive. Siderophores expression during salmonella replication within macrophages and Vibrio cholerae bacteremia is being explored as potential therapeutic targets to combat these pathogens.
Vibrio cholera is primarily known to cause the deliberating diarrhoea disease cholera. However, the non- toxigenic V. cholerae strains (NOVC) can cause bacteremia, especially in immunocompromised individuals. Currently, all reported toxins of V. cholerae are enterotoxins with no invasive properties. The ability of the bacterium to overcome host complement systems and express certain genes might enable its persistence in blood. Our preliminary investigations have identified the cholix toxin and certain siderophores as potential virulence factors contributing to bloodstream infection. These data were obtained following whole genome sequence analysis of strains that survived bactericidal action of human
serum. To explore further on this, we want to delete these genes to confirm their role in V. cholerae bacteremia. In-frame deletions would be created and single knock-out mutants tested for serum resistance. The overall outcome of this project is to contribute to our understanding of the pathogenesis of Vibrio bacteremia and potentially identified therapeutic targets to control this rare but fatal infection.
Adade NE, Ahator SD, GarcíaRomero I, Algarañás M, Appiah V, Valvano MA, Duodu S. 2025. Stres s adaptation under in vitro evolution influences survival and metabolic phenotypes of clinical and environmental strains of Vibrio cholerae El-Tor. Microbiol Spectr 13:e01211-24.
https://doi.org/10.1128/spectrum.01211-24
Sam EK, Alagbo J, Asamoah A, Ansah F, Tandoh KZ, Amenga-Etego LN, Duodu S (2024). Diagnostic performance of Typhidot RDT in diagnosis of typhoid fever and antibiotic resistance characterisation in a cross-sectional study in Southern Ghana. BMC Infect Dis 24, 1262
https://doi.org/10.1186/s12879-024-10160-2
Agyei FK, Scharf BD and Duodu S (2024). Vibrio cholerae Bacteremia: An Enigma in Cholera- Endemic African Countries. Tropical medicine and infectious disease, 9(5), 103. https://doi.org/10.3390/tropicalmed9050103
Makhalanyane T P, Bezuidt OKI, Pierneef RE, Mizrachi E, Zeze A, Fossou RK, Kouadjo CG, Duodu S, Chikere CB, Babalola OO, Klein A, Keyster M, du Plessis M, Yorou NS, Hijri M, Rossouw T, Kamutando CN, Venter S, Moleleki LN and Murrell C (2023). African microbiomes matter. Nature Adade NE, Aniweh Y, Mosi L, Valvano MA, Duodu S, & Ahator SD (2022). Comparative analysis of Vibrio cholerae isolates from Ghana reveals variations in genome architecture and adaptation of outbreak and environmental strains. Frontiers in microbiology, 13, 998182. https://doi.org/10.3389/fmicb.2022.998182
Genetic knock out and mutational analysis, qPCR, gene expression, transcripts profiling, whole genome sequencing and analysis, Bacterial and Mammalian cell culture assays, Microscopy.
The lab is made up of interns, final year undergraduate students, visiting students as well as masters and PhD students at different levels in their program. In my lab, the research interest is cancer biology. This includes immunology, cell biology and molecular biology of cancer as well
as benign tumors such as fibroids. The overarching goal of the research in my lab is to identify factors relating to cancer progression and thereby contributing to findings that would give insights and better strategies for improving chemotherapeutics for cancer. Currently we have been investigating the effect of some natural compounds on cancer progression with the aim of identifying the anti-cancer potentials of these natural compounds and how they can be used in combination with existing conventional chemotherapy. We are also trying to understand how chemotherapy alters the immune profiles, circulating tumor cells and other molecular markers in breast cancer patients with the aim of coming up with findings that would give insights and better strategies for improving chemotherapeutics for cancer. We also study the differential expression of target genes in tumor tissues to determine whether they can be used as biomarkers or therapeutic targets. We have also been studying the differential expression of genes in fibroid tissues and non-fibroid tissues in women of African origin with the aim of better understanding the pathogenesis of fibroids which is very common in women.
Endometrial cancer (EC) is increasingly becoming common among women globally. Currently, it is the most common gynecological malignancy in developed countries and the 6 th most common cancer in women globally. The use of histology alone for diagnosis provides limited information for patient management. The introduction of genomic classification has provided a refined understanding of the disease, highlighting distinct subtypes with implications for prognosis and treatment. EC POLE ultramutated, deficient Mismatch Match Repair (dMMR), P53 abnormal and No Specific Molecular Profile (NSMP) are the four main molecular subtypes identified by The Cancer Genome Atlas (TCGA) and these are valuable for prognosis and for guiding personalized treatment. In sub-Saharan Africa however, data on genomic characteristics of
endometrial cancer and their clinical impact is scarce. The aim of the study is to investigate the mutations in the molecular subtypes of EC in Ghanaian women using the genomic markers POLE mutations, p53 abnormalities, and mismatch repair deficiency (dMMR). After obtaining ethical approval, clinical and pathological data will be retrieved from data records. Formalin-fixed tissue blocks will be retrieved. Thin sections will be prepared for molecular analysis (IHC for analysis of P53 and mismatch repair (MMR) status and Sanger sequencing for POLE mutation analysis. The data will be analysed for 5-year progression free survival (PFS). Kaplan Meier curves and Cox proportional hazard ratios will be used to asses effect on 5-year PFS. Findings from the study will contribute to the understanding of the genomic profile of EC in sub-Saharan Africa.
Ofori, B., Fosu, K., Aikins, A. R., Amofa, K., & Sarpong, N. (2025). The intersection of culture and prostate cancer care in Sub-Saharan Africa: a systematic review. African Journal of Urology 2025 31:1, 31(1), 1–17. https://doi.org/10.1186/S12301-025-00512-Y
Serwaa, A., Oyawoye, F., Owusu, I. A., Dosoo, D., Manu, A. A., Sobo, A. K., Fosu, K., Olwal, C. O., Quashie, P. K., & Aikins, A. R. (2024). In vitro analysis suggests that SARS-CoV-2 infection differentially modulates cancer-like phenotypes and cytokine expression in colorectal and
prostate cancer cells. Scientific Reports, 14(1), 24625. https://doi.org/10.1038/S41598-024- 75718-1
Fosu, K., Quarshie, J. T., Offei, N. A., Serwaa, A., Tuah, B., Sobo, A. K., Kotei Amon, J. N., Nketiah Sarpong, K. A., & Aikins, A. R. (2024). Caffeic Acid Phenethyl Ester Suppresses Cytokine- and Chemotherapy-Induced Inflammation in Triple-Negative Breast Cancer via NF-κB Signalling. Natural Product Communications, 19(11). https://doi.org/10.1177/1934578X241298830
Abdulkarim, S., Quarshie, J. T., Birokorang, P. A., Mawuli, M. A., Baffoe, S. M., Abrahams, A. O. D., & Aikins, A. R. (2024). Role of the IL-8/CXCR2 axis in promoting vasculogenic mimicry in triple-negative breast cancer through epithelial-mesenchymal transition. Cancer Plus 2024,
6(2), 3356, 6(2), 3356. https://doi.org/10.36922/CP.3356
Quarshie, J. T., Fosu, K., Offei, N. A., Sobo, A. K., Quaye, O., & Aikins, A. R. (2023). Cryptolepine Suppresses Colorectal Cancer Cell Proliferation, Stemness, and Metastatic Processes by Inhibiting WNT/β-Catenin Signaling. Pharmaceuticals (Basel, Switzerland), 16(7).
https://doi.org/10.3390/PH16071026
Major lab techniques include cell culture, microscopy, MTT assay, wound healing assay, colony formation assay, flow cytometry, ELISA, Polymerase chain reaction, western blot.
Links to the programmes in the University
WACCBIP PhD programmes
https://www.waccbip.org/our-programmes/doctoral/
WACCBIP Masters programmes
Grow. Play. Lead. Providing opportunities for our youth to become the best in all areas of their lives.